ოთხშაბათი, აპრილი 15, 2026
- Advertisement -
Google search engine
Global Ingredient Risk Index Excipient

Gum Arabic (Acacia)

Acacia Senegal / Acacia seyal gum exudate

Also known as: gum arabic, acacia gum, acacia, E414, gum acacia

LOW RISK 2.0/10 How?

This ingredient is classified as unclassified risk (GIRI score: 2.0/10).

02

Safety Profile

Known Safety Concerns

  • Cross-reactivity with legume/peanut allergy in rare cases
  • Osmotic diarrhoea and flatulence at high amounts
  • FDA GRAS -- safe at typical supplement amounts
  • Prebiotic benefit at higher doses

Contraindications

  • Cross-reactivity with legume/peanut allergy in rare cases
  • Osmotic diarrhoea and flatulence at high amounts
═══════════════════════════════════════════════════════════════════════ -->
03

Interactions

Information not yet available for this ingredient profile.

═══════════════════════════════════════════════════════════════════════ -->
04

Evidence and Scientific Findings

Overview

Ingredient Overview

Gum arabic is a natural polysaccharide exudate from Acacia trees used as an emulsifier, binder, and prebiotic fibre. FDA GRAS status. Fermented by gut bacteria producing short-chain fatty acids — prebiotic effect. Cross-reactivity with legume allergies in rare cases. High amounts cause GI distress.

Classification

Biological and Chemical Classification

Scientific Name
Acacia Senegal / Acacia seyal gum exudate
Mechanism

Mechanism of Action

Information not yet available for this ingredient profile.

Clinical Evidence

Clinical Evidence of Effectiveness

Information not yet available for this ingredient profile.

Pharmacokinetics

Pharmacokinetics

Information not yet available for this ingredient profile.

Dosage

Recommended Dosage

Information not yet available for this ingredient profile.

═══════════════════════════════════════════════════════════════════════ -->
05

SETI — Scientific Evidence Transparency Index

SETI Score 50/100
Risk Level High risk
Scientific Confidence Low
Evidence Strength Limited
Key Benefit Excipient
Key Safety Concern Cross-reactivity with legume/peanut allergy in rare cases
Evidence Reviewed 10 PubMed studies
Scientific Confidence Low
Based on study quality, consistency, and recency

Executive Summary — Ingredient Assessment

SETI Score 50/100
Risk Level High risk
Evidence Strength Limited
Main Benefit Excipient
Main Safety Concern Cross-reactivity with legume/peanut allergy in rare cases
Ingredient Gum Arabic (Acacia)
Scientific name Acacia Senegal / Acacia seyal gum exudate
Scientific Evidence Overview
  • 10 studies reviewed
  • 0 high-quality studies (meta-analysis or RCT)
  • Main clinical benefit observed: Excipient
  • Evidence consistency: High consistency across studies (100%)
Safety Signals
  • Cross-reactivity with legume/peanut allergy in rare cases
  • Osmotic diarrhoea and flatulence at high amounts
  • FDA GRAS -- safe at typical supplement amounts
  • Prebiotic benefit at higher doses
Evidence Strength Limited
Final Scientific Assessment

The available scientific evidence for Gum Arabic (Acacia) indicates notable safety signals that warrant caution. Use should be considered carefully and monitored, particularly in sensitive populations or alongside other medications.

Ingredient Gum Arabic (Acacia)
Evidence reviewed 10 peer-reviewed studies (last 10 years)
Scientific name Acacia Senegal / Acacia seyal gum exudate
50 /100

Total SETI Score

High risk
Evidence quality 10/40
Evidence consistency 20/20
Safety signals 0/20
Study recency 10/10
Evidence transparency 10/10

Evidence Summary

  • 10 studies reviewed
  • 0 high-quality studies (meta-analysis or systematic review)
  • 0 studies identified benefits or no safety concern (GREEN)
  • 10 studies reported limited or advisory safety evidence (YELLOW)

Evidence Policy

Only peer-reviewed scientific literature indexed in PubMed or comparable databases is included in this evaluation. Commercial websites, blogs, and marketing materials are excluded. All references include direct traceable links to source documents.

Last updated: 25 მარ 2026, 12:59

Evidence Distribution

10 Other / unclassified
  1. Observational / other LOW evidence YELLOW
    The effectiveness of Sumbawa fermented mare's milk powder with gum arabic [Acacia senegal (L.) Willd] microencapsulant as a modified traditional healthy food. ↗
    Journal J Adv Vet Anim Res
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Utama AH et al.. The effectiveness of Sumbawa fermented mare's milk powder with gum arabic [Acacia senegal (L.) Willd] microencapsulant as a modified traditional healthy food.. J Adv Vet Anim Res. 2025. PMID:41069721.
  2. Observational / other LOW evidence YELLOW
    Therapeutic Potential of Gum Arabic (Acacia senegal) in Chronic Kidney Disease Management: A Narrative Review. ↗
    Journal J Clin Med
    Year 2024
    Study type Observational / other
    Evidence strength LOW evidence
    Alobaidi S. Therapeutic Potential of Gum Arabic (Acacia senegal) in Chronic Kidney Disease Management: A Narrative Review.. J Clin Med. 2024. PMID:39407837.
  3. Observational / other LOW evidence YELLOW
    Gum acacia dietary fiber: Significance in immunomodulation, inflammatory diseases, and cancer. ↗
    Journal Phytother Res
    Year 2024
    Study type Observational / other
    Evidence strength LOW evidence
    Barkeer S et al.. Gum acacia dietary fiber: Significance in immunomodulation, inflammatory diseases, and cancer.. Phytother Res. 2024. PMID:38272848.
  4. Observational / other LOW evidence YELLOW
    Effects of Gum Arabic (Acacia senegal) Powder on Characteristics of Carcass and Breast Meat Quality Parameters in Male Broiler Chickens. ↗
    Journal Foods
    Year 2023
    Study type Observational / other
    Evidence strength LOW evidence
    Al-Baadani HH et al.. Effects of Gum Arabic (Acacia senegal) Powder on Characteristics of Carcass and Breast Meat Quality Parameters in Male Broiler Chickens.. Foods. 2023. PMID:37444264.
  5. Observational / other LOW evidence YELLOW
    Gum Acacia attenuates cisplatin toxic effect spermatogenesis dysfunction and infertility in rats. ↗
    Journal Int J Biol Macromol
    Year 2023
    Study type Observational / other
    Evidence strength LOW evidence
    Nofal AE et al.. Gum Acacia attenuates cisplatin toxic effect spermatogenesis dysfunction and infertility in rats.. Int J Biol Macromol. 2023. PMID:37030465.
  6. Observational / other LOW evidence YELLOW
    Evaluation of gum Arabic (Acacia Senegal) as a natural prebiotic to improve growth performance and health status of broiler chickens. ↗
    Journal Trop Anim Health Prod
    Year 2022
    Study type Observational / other
    Evidence strength LOW evidence
    Al-Baadani HH et al.. Evaluation of gum Arabic (Acacia Senegal) as a natural prebiotic to improve growth performance and health status of broiler chickens.. Trop Anim Health Prod. 2022. PMID:35913613.
  7. Observational / other LOW evidence YELLOW
    The Effect of Gum Arabic (Acacia Senegal) on Cardiovascular Risk Factors and Gastrointestinal Symptoms in Adults at Risk of Metabolic Syndrome: A… ↗
    Journal Nutrients
    Year 2021
    Study type Observational / other
    Evidence strength LOW evidence
    Jarrar AH et al.. The Effect of Gum Arabic (Acacia Senegal) on Cardiovascular Risk Factors and Gastrointestinal Symptoms in Adults at Risk of Metabolic Syndrome: A Randomized Clinical Trial.. Nutrients. 2021. PMID:33435475.
  8. Observational / other LOW evidence YELLOW
    Comparative efficacy of Gum Arabic (Acacia senegal) and Tribulus terrestris on male fertility. ↗
    Journal Saudi Pharm J
    Year 2020
    Study type Observational / other
    Evidence strength LOW evidence
    Nasir O et al.. Comparative efficacy of Gum Arabic (Acacia senegal) and Tribulus terrestris on male fertility.. Saudi Pharm J. 2020. PMID:33424268.
  9. Observational / other LOW evidence YELLOW
    Fabrication of a Greener TiO(2)@Gum Arabic-Carbon Paste Electrode for the Electrochemical Detection of Pb(2+) Ions in Plastic Toys. ↗
    Journal ACS Omega
    Year 2020
    Study type Observational / other
    Evidence strength LOW evidence
    Sivan SK et al.. Fabrication of a Greener TiO(2)@Gum Arabic-Carbon Paste Electrode for the Electrochemical Detection of Pb(2+) Ions in Plastic Toys.. ACS Omega. 2020. PMID:33043219.
  10. Observational / other LOW evidence YELLOW
    A gum Arabic assisted sustainable drug delivery system for adult Drosophila. ↗
    Journal Biol Open
    Year 2020
    Study type Observational / other
    Evidence strength LOW evidence
    Liang Q et al.. A gum Arabic assisted sustainable drug delivery system for adult Drosophila.. Biol Open. 2020. PMID:32487516.
═══════════════════════════════════════════════════════════════════════ -->
06

Score Transparency

Q × L × D × S × 10 = 2.0 / 10

The GIRI Score is the product of four independently computed evidence components, each normalised to 0–1, then scaled to 0–10. Every component is derived exclusively from peer-reviewed references and regulatory data — no editorial judgement is applied.

Q
Evidence Quantity 0 / 10
0%

0 of 10 approved references (score saturates at 10). More peer-reviewed studies = stronger evidence base.

Method: Q = number of approved references ÷ 10 (capped at 1.0)

L
Evidence Quality 5 / 10
50%

Limited — mostly case reports or animal studies

Method: L = mean study-level weight across approved references. Level 1 (meta-analysis / systematic review) = 1.0; Level 2 (RCT) = 0.8; Level 3 (cohort/case-control) = 0.6; Level 4 (case report) = 0.4; Level 5 (animal / in-vitro) = 0.2.

D
Evidence Direction 5 / 10
Benefit
Risk
50%

Mixed or neutral — roughly equal benefit and risk signals

Method: D = (sum of risk-scored references − sum of benefit-scored references) ÷ total evidence score, then scaled from [−1, 1] to [0, 1]. 0.0 = pure benefit; 0.5 = neutral; 1.0 = pure risk.

S
Safety Signals 5 / 10
50%

One or more monitoring-level safety signals active

Method: S = 0.5 (neutral baseline) + sum of active signal severity deltas ÷ 10. Severity deltas: Critical = +2.0, High = +1.5, Moderate = +1.0, Low = +0.5. Capped at 1.0.

0Q × 5L × 5D × 5S = 2.0 / 10

Final GIRI Score for Gum Arabic (Acacia). Risk level thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.

Full methodology & data sources

The GIRI Score is computed entirely from structured data — no editorial scoring or subjective weighting is applied at any step.

  • References: Only approved references are counted. Each reference is assigned an evidence level (L1–L5) and a direction (risk / neutral / benefit) by the reference manager or AI classifier.
  • Safety Signals: Sourced from regulatory agencies (FDA, EMA, Health Canada, TGA, and others) and pharmacovigilance databases. Only active signals count toward the score.
  • Formula version: GIRI Score v3.7.0 — Q × L × D × S × 10.
  • Limitations: The score reflects published evidence and recorded signals as of the last update date. It is not a clinical risk assessment and should not replace advice from a qualified healthcare professional.
07

Risk Level Classification

LOW RISK 2.0/10

Based on available regulatory signals and scientific evidence, this ingredient presents a low safety concern under normal conditions of use.

LOW
0–3.0
MODERATE
3.0–5.5
HIGH
5.5–7.5
CRITICAL
7.5–10
2.0

The score pin shows exactly where this ingredient falls on the fixed risk scale.

What drove the Low classification for Gum Arabic (Acacia)

GIRI Score 2.0 / 10

A score of 2.0 places this ingredient in the Low band. Thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.

Evidence Quantity (Q) 0 / 10 refs

0 approved references.

Evidence Quality (L) 50%

Limited — mostly case reports or animal studies (Level 4–5).

Evidence Direction (D) 50% toward risk

Neutral or mixed — benefit and risk signals roughly balanced.

Safety Signals (S) 0 active signals

No active signals — S component is at neutral baseline (0.5), contributing no extra risk weight.

Regulatory Status No restrictions found

No major regulatory restrictions or advisories recorded across monitored jurisdictions (FDA, EMA, Health Canada, TGA, and others).

How are the Low / Moderate / High / Critical thresholds defined?

The four risk levels are fixed score bands. A score is assigned to exactly one level based on where it falls:

LevelScoreMeaning
LOW0.0 – 2.9Sparse or predominantly beneficial evidence. No active safety alerts.
MODERATE3.0 – 5.4Mixed signals — some risk alongside benefit. Caution at high doses or in sensitive groups.
HIGH5.5 – 7.4Multiple studies or regulatory alerts documenting adverse effects. Professional oversight recommended.
CRITICAL7.5 – 10Regulatory restrictions in one or more major jurisdictions. Serious documented harm. Avoid without specialist supervision.

Thresholds are fixed constants (GIRI_Score_Utils::LEVEL_THRESHOLDS). They do not change per ingredient and are never subject to editorial adjustment.